Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in

Heath D Skinner1, Uma Giri2, Liang P Yang3

  • 1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. hskinner@mdanderson.org.

Insights

Local treatment failure in head and neck squamous cell carcinoma (HNSCC) is linked to increased PD-L1 expression. Targeting the Axl-PI3 kinase-PD-L1 axis may overcome radiation resistance in HNSCC patients.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Cancer Biology

Background:

  • Head and neck squamous cell carcinoma (HNSCC) often results in death due to local treatment failure.
  • Understanding the mechanisms of radiation resistance is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying local treatment failure in HNSCC.
  • To identify potential therapeutic targets for overcoming radiation resistance.

Main Methods:

  • Utilized radiation-resistant (RR) HPV-negative HNSCC cell lines and patient tumor cohorts.
  • Performed genomic, transcriptomic, and proteomic analyses, including Reverse Phase Protein Arrays (RPPA) and immunohistochemistry.
  • Correlated protein and gene expression with clinical outcomes following radiotherapy.

Main Results:

  • Radiation-resistant cell lines showed increased expression of Axl, PI3 kinase signaling, and PD-L1.
  • Inhibition of Axl or PI3 kinase reduced PD-L1 expression.
  • High PD-L1 expression in patient tumors significantly correlated with local treatment failure after radiotherapy (failure rates of 50-70% vs. 20-25%).
  • Low PD-L1 expression combined with high CD8+ tumor-infiltrating lymphocytes was associated with no local failure or disease-related death.

Conclusions:

  • A targetable Axl-PI3 kinase-PD-L1 signaling axis is strongly associated with radioresistance in HNSCC.
  • This axis represents a potential therapeutic strategy to enhance radiotherapy efficacy.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K